How Schools Have Responded to the Youth Fentanyl Crisis
With the onset of the COVID-19 pandemic, deaths due to drug overdose among adolescents more than doubled, primarily driven by the synthetic opioid, fentanyl.
With the onset of the COVID-19 pandemic, deaths due to drug overdose among adolescents more than doubled, primarily driven by the synthetic opioid, fentanyl.
As speculation about whether Medicaid cuts will be part of the solution to our national debt problem continues, no one can predict how much the Medicaid rollback will be, or its impact on the one in five Americans who rely on it. The post When Medicaid Cost Cutting Is Simply Cost Shifting appeared first on…
This fact sheet provides a snapshot of global malaria efforts and examines the U.S. government’s role in addressing malaria worldwide, including current programs, funding, and key issues.
A new analysis shows that individuals with employer insurance could save 41% on their out-of-pocket spending for asthma and COPD inhalers through manufacturer savings. In response to a U.S. Senate investigation into inhaler costs, 3 drug makers voluntarily capped out-of-pocket costs on their brand-name asthma and COPD inhalers.
Underscoring the massive scale of America’s medical debt problem, a New York-based nonprofit has struck a deal to pay off old medical bills for an estimated 20 million people. Undue Medical Debt, which buys patient debt, is retiring $30 billion worth of unpaid bills in a single transaction with Pendrick Capital Partners, a Virginia-based debt…
The non-responder gap matters for two reasons: First, patients who are in an advanced stage of cancer lose valuable time in ineffective therapy. Second, it increases the cost of therapy and resources for both patients and the broader healthcare ecosystem. The post An AI Driven Approach to Address the Non-Responder Gap in Radiopharmaceutical Therapy appeared…
By MIKE MAGEE The incoming Trump Administration nominees for positions in Health and Human Services (like RFK Jr. to direct the department and Mehmet Oz to head Medicare and Medicaid Services) are names you know and apparently many trust? In this morning’s New York Times, Dr. Ashish Jha, President Biden’s Covid lead, thinks he knows why….